Clinical Trial Update: Thiotepa Plus Fludarabine+ Melphalan as the Preparative Regime for Alternative Donor Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluating thiotepa, fludarabine, and melphalan as a preparative regimen for alternative donor transplantation in leukemia have been compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• Fludarabine (Fludarabine)
• Melphalan (Melphalan)
• THIOTEPA (THIOTEPA)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2025-12-03